• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Nephrol . Impact of Renal Function on Admission in COVID-19 Patients: An Analysis of the International HOPE COVID-19 (Health Outcome Predictive E

tetano

Editor, Senior Moderator
J Nephrol


. 2020 Jun 29.
doi: 10.1007/s40620-020-00790-5. Online ahead of print.
Impact of Renal Function on Admission in COVID-19 Patients: An Analysis of the International HOPE COVID-19 (Health Outcome Predictive Evaluation for COVID 19) Registry

Aitor Uribarri[SUP] 1 [/SUP], Iv?n J N??ez-Gil[SUP] 2 [/SUP], Alvaro Aparisi[SUP] 3 [/SUP], Victor M Becerra-Mu?oz[SUP] 4 [/SUP], Gisela Feltes[SUP] 5 [/SUP], Daniela Trabattoni[SUP] 6 [/SUP], Inmaculada Fern?ndez-Rozas[SUP] 7 [/SUP], Mar?a C Viana-Llamas[SUP] 8 [/SUP], Martino Pepe[SUP] 9 [/SUP], Enrico Cerrato[SUP] 10 [/SUP], Thamar Capel-Astrua[SUP] 11 [/SUP], Rodolfo Romero[SUP] 12 [/SUP], Alex F Castro-Mej?a[SUP] 13 [/SUP], Ibrahim El-Battrawy[SUP] 14 15 [/SUP], Javier L?pez-Pa?s[SUP] 16 [/SUP], Fabrizio D'Ascenzo[SUP] 17 [/SUP], Oscar Fabregat-Andres[SUP] 18 [/SUP], Alfredo Bardaj?[SUP] 19 [/SUP], Sergio Raposeiras-Roubin[SUP] 20 [/SUP], Francisco Mar?n[SUP] 21 [/SUP], Antonio Fern?ndez-Ortiz[SUP] 2 [/SUP], Carlos Macaya[SUP] 2 [/SUP], Vicente Estrada[SUP] 2 [/SUP], HOPE COVID-19 Investigators


AffiliationsExpand

Abstract

Background: Coronavirus disease 2019 (COVID-19) is a disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Despite its international aggressive extension, with a significant morbidity and mortality, the impact of renal function on its prognosis is uncertain.
Methods: Analysis from the international HOPE-Registry (NCT04334291). The objective was to evaluate the association between kidney failure severity on admission with the mortality of patients with SARS-CoV-2 infection. Patients were categorized in 3 groups according to the estimated glomerular filtration rate on admission (eGFR > 60 mL/min/1.73 m[SUP]2[/SUP], eGFR 30-60 mL/min/1.73 m[SUP]2[/SUP] and eGFR < 30 mL/min/1.73 m[SUP]2[/SUP]).
Results: 758 patients were included: mean age was 66 ? 18 years, and 58.6% of patient were male. Only 8.5% of patients had a history of chronic kidney disease (CKD); however, 30% of patients had kidney dysfunction upon admission (eGFR < 60 mL/min/1.73 m[SUP]2[/SUP]). These patients received less frequently pharmacological treatment with hydroxychloroquine or antivirals and had a greater number of complications such as sepsis (11.9% vs 26.4% vs 40.8%, p < 0.001) and respiratory failure (35.4% vs 72.2% vs 62.0%, p < 0.001) as well as a higher in-hospital mortality rate (eGFR > 60 vs eGFR 30-60 vs and eGFR < 30, 18.4% vs 56.5% vs 65.5%, p < 0.001). In multivariate analysis: age, hypertension, renal function, 0[SUP]2[/SUP] saturation < 92% and lactate dehydrogenase elevation on admission independently predicted all-cause mortality.
Conclusions: Renal failure on admission in patients with SARS-CoV-2 infection is frequent and is associated with a greater number of complications and in-hospital mortality. Our data comes from a multicenter registry and therefore does not allow to have a precise mortality risk assessment. More studies are needed to confirm these findings.

Keywords: Acute kidney injury; COVID-19; Chronic kidney failure; Mortality; Prognosis; Registry.
 
Back
Top Bottom